Tenders Are Invited For Open-House Procedure - Div. Active Ingredients From October 1St, 2022

Work Detail

Open-House Procedure - Div. Active Ingredients From October 1St, 2022. Conclusion Of Non-Exclusive Discount Agreements According To 130 A Paragraph 8 Sgb V With The Possibility Of Conclusion At Any Time As Part Of The So-Called Open House Procedure For Various Active Pharmaceutical Ingredients With The Earliest Possible Start Of The Contract On October 1St, 2022. . The Specific Active Pharmaceutical Ingredients And The Start Of Each Contract Can Be Found In The Current List Of Active Pharmaceutical Ingredients In The Project Room Of The Procurement Portal Dtvp Under The Heading Award Documents. . As Of October 1St, 2022, Contracts For The Following Active Ingredients Will Be Offered: . Abacavir / Lamivudine / Zidovudine Acetylcysteine_Nonrx Nonrx Acetylcysteine_Rx Rx Acetylsalicylic Acid Only Products That Can Be Prescribed According To Annex 1 Amrl Gba Acitretin Adefovir Dipivoxil Alitretinoin Amifampridine Anagrelide Except N3 Packs Of The Dar Hkp With 0.5 Mg Strength Aripiprazole Excluding Dar Tablets/Orodispersible Tablets And Oral Solutions Atorvastatin/Ezetimibe Beclometasone/Formoterol Beclomethasone/Formoterol/Glycopyrronium Bimatoprost Biperids Bortezomib Brivudin Budesonide Excluding Inhalants Calcipotriol Calcium / Colecalciferol Ceftriaxone Clomipramine 75 Mg Strength, Prolonged-Release Clostridium Botulinum Excluding Lifestyle Drugs Cholecalciferol Nonrx Colecalciferol Rx Colistin Cyproterone Deferasirox Desloratadine Desogestrel / Ethinyl Estradiol Dienogest Dienogest / Ethinyl Estradiol Diltiazem Distiguished Dornase Alpha Dronedaron Drospirenone / Ethinyl Estradiol Ebastin Iron Ii Oral Dar/Products That Can Only Be Prescribed According To Annex 1 Amrl Gba Enoxaparin 20 Mg And 40 Mg 20 Mg And 40 Mg Strength Enoxaparin 60 Mg, 80 Mg And 100 Mg 60 Mg, 80 Mg And 100 Mg Strength Ertugliflozin Erythropoietin Epoietin Eslicarbazepine Estradiol Etanercept Etravirine Everolimus Fampridine Fentanyl Filgrastim Flupentixol Decanoate Follitropin Alfa Follitropin Beta Fondaparinux Sodium Fusidic Acid Fusidic Acid / Betamethasone Glatiramer Acetate (40Mg Potency Dar Pen) Goserelin Hydrocortisone Hydromorphone Dar Solution For Injection/Infusion Hydroxychloroquine Hydroxyzine Ibuprofen (Nonrx, Liquid Oral Dosage Forms) Ibuprofen (Rx 400Mg And 600Mg) Ibuprofen (Rx 800 Mg Prolonged-Release) Ibuprofen (Rx 800Mg Non-Retarded) Imatinib Infliximab Interferon Beta 1A Avonex(R) Interferon Beta 1A Rebif(R) Lanreotide Lenalidomide Lenograstim Leuprorelin Lidocaine Dar Patches Lipegfilgrastim Loperamide Lopinavir / Ritonavir Macrogol Only Products That Can Be Prescribed According To Annex 1 Amrl Gba Macrogol Only Medical Devices That Can Be Prescribed According To Annex 5 Amrl Gba Meloxicam Meropenem Methocarbamol Except Dar Film-Coated Tablets With An Active Substance Strength Of 750 Mg Metoclopramide Midazolam Minocycline Nadroparin Natalizumab Excluding Subcutaneous Use Nitisinone Octreotide Olmesartan / Amlodipine / Hct Oxycodone / Naloxone Paliperidone Palonosetron Pancreatin Paracetamol Only Products That Can Be Prescribed According To Annex 1 Amrl Gba Pegfilgrastim Peginterferon Beta1a Pemetrexed Perindopril / Indapamide Perindopril/Amlodipine Promethazine Pyridostigmine Rabeprazole Raltegravir Risperidone Only Dry Substances With Solvent And Powder And Solvent For Solution For Injection Ritonavir Rituximab Roflumilast Rosuvastatin/Ezetimibe Rotigotine Rupatadine Silodosin Somatropin Sorafenib Sulfasalazine Sunitinib Tacrolimus Tadalafil Exclusively Indication Bph Tapentadol Teriparatide Timolol / Bimatoprost Dar Eye Drops In Single-Dose Container Tiotropium Bromide Inh Tobramycin Tolvaptan Tramadol / Paracetamol Trastuzumab Travoprost / Timolol Triptorelin Zidovudine Zolmitriptan . The Contracts All End On September 30, 2024.

Contact Information

Other Detail